Evidence map›Paper›PMID 42751003›Full record

ArticleEpilepsy & behavior reports2026

Severe acute respiratory distress syndrome in Dravet syndrome: Clinical cases expanding the extraneurological phenotype.

R Montero-Yéboles, E de Frutos-Porras, E Ulloa-Santamaría, M A García Pérez, M Bueno-Campaña, B Ruiz-Sáez

Abstract readCase Reports
In one paragraph

Article in Epilepsy & behavior reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

R Montero-YébolesHospital Reina Sofía, Córdoba, Spain.
E de Frutos-PorrasHospital Fundación Alcorcón, Madrid, Spain.
E Ulloa-SantamaríaHospital Reina Sofía, Córdoba, Spain.
M A García PérezHospital Fundación Alcorcón, Madrid, Spain.
M Bueno-CampañaHospital Fundación Alcorcón, Madrid, Spain.
B Ruiz-SáezHospital Reina Sofía, Córdoba, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Dravet syndrome (DS) is increasingly recognized as a multisystem disorder extending beyond epilepsy. We describe two children with genetically confirmed DS who developed recurrent, severe episodes of acute respiratory distress syndrome (ARDS), suggesting a previously underrecognized extraneurological manifestation. Methods: Clinical, genetic, and pediatric intensive care data were retrospectively reviewed. Results: Both patients experienced severe ARDS triggered by febrile illnesses or status epilepticus. One child developed recurrent ARDS associated with viral respiratory infections, requiring multiple pediatric intensive care unit admissions with invasive or noninvasive ventilatory support. The second patient developed life-threatening ARDS following status epilepticus, requiring prolonged mechanical ventilation and repeated veno-venous extracorporeal membrane oxygenation for refractory hypoxemia. In both cases, ARDS occurred in the absence of ongoing seizures during critical illness. Significance: These cases expand the recognized extraneurological phenotype associated with SCN1A-related Dravet syndrome and suggest a potential vulnerability to severe inflammatory respiratory failure. Increased awareness of this association may have important implications for risk stratification, monitoring, and multidisciplinary management of children with DS during febrile illnesses and status epilepticus.

Indexed as

Acute respiratory distress syndromeARDSDravet syndromeExtracorporeal membrane oxygenationMultisystem diseasePediatric epilepsySCN1A

Identifiers

PMID42751003
PMCPMC13579307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.